Karolinska University Hospital Solna
Stockholm, 17176, Sweden
Completed
NCT Number: NCT05385107
Value of PCT When Diagnosing Candidemia
This study is a retrospective analysis to identify and compare the shift in inflammatory biomarkers in ICU patients immediately before and after the first identification of candidemia.
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
As above.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(all has to be fullfilled):
- ICU patients with blood cultures showing growth of Candida species
- clinical records including daily data on WBC, CRP, Procalcitonin and body temperature
Exclusion criteria
- Age lower than 18 years
- blood cultures with growth of Candida species before ICU admission
- incomplete records of daily WBC, CRP, Procalcitonin or body temperature
Treatment and study plan
Serum procalcitonin concentration
Diagnostic TestPrimary outcomes
-
Absolute procalcitonin concentration
Time frame: 9 days
-
Shift (trend) procalcitonin concentration
Time frame: 9 days
Sponsors and collaborators
Lead sponsor
Karolinska University Hospital
Other
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2015
- Study completion
- 2021
- First posted
- May 23, 2022
- Registry last updated
- May 23, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.